These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12884069)

  • 1. Incidence and risk factors for nosocomial infections caused by fluoroquinolone-resistant Escherichia coli.
    Huotari K; Tarkka E; Valtonen V; Kolho E
    Eur J Clin Microbiol Infect Dis; 2003 Aug; 22(8):492-5. PubMed ID: 12884069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli.
    Colodner R; Kometiani I; Chazan B; Raz R
    Infection; 2008 Feb; 36(1):41-5. PubMed ID: 18193386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for ambulatory urinary tract infections caused by high-MIC fluoroquinolone-susceptible Escherichia coli in women: results from a large case-control study.
    Rattanaumpawan P; Nachamkin I; Bilker WB; Roy JA; Metlay JP; Zaoutis TE; Lautenbach E;
    J Antimicrob Chemother; 2015 May; 70(5):1547-51. PubMed ID: 25630645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates.
    Lin CY; Huang SH; Chen TC; Lu PL; Lin WR; Chen YH
    J Microbiol Immunol Infect; 2008 Aug; 41(4):325-31. PubMed ID: 18787740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular epidemiology of quinolone-resistant Escherichia coli isolated from urinary tract infection.
    Eom JS; Hwang BY; Sohn JW; Kim WJ; Kim MJ; Park SC; Cheong HJ
    Microb Drug Resist; 2002; 8(3):227-34. PubMed ID: 12363013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate.
    Dumford D; Suwantarat N; Bhasker V; Kundrapu S; Zabarsky TF; Drawz P; Zhu H; Donskey CJ
    Infect Control Hosp Epidemiol; 2013 Mar; 34(3):269-73. PubMed ID: 23388361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea.
    Cheong HJ; Yoo CW; Sohn JW; Kim WJ; Kim MJ; Park SC
    Clin Infect Dis; 2001 Jul; 33(1):48-53. PubMed ID: 11389494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
    Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A
    Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli.
    Wu HH; Liu HY; Lin YC; Hsueh PR; Lee YJ
    J Microbiol Immunol Infect; 2016 Jun; 49(3):424-9. PubMed ID: 22560475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection.
    van der Starre WE; van Nieuwkoop C; Paltansing S; van't Wout JW; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; Blom JW; van Dissel JT
    J Antimicrob Chemother; 2011 Mar; 66(3):650-6. PubMed ID: 21123286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.
    Colodner R; Rock W; Chazan B; Keller N; Guy N; Sakran W; Raz R
    Eur J Clin Microbiol Infect Dis; 2004 Mar; 23(3):163-7. PubMed ID: 14986159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study.
    Ahn JY; Song JE; Kim MH; Choi H; Kim JK; Ann HW; Kim JH; Jeon Y; Jeong SJ; Kim SB; Ku NS; Han SH; Song YG; Yong D; Lee K; Kim JM; Choi JY
    Am J Infect Control; 2014 Jun; 42(6):621-5. PubMed ID: 24837112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence and dissemination of quinolone-resistant Escherichia coli in the community.
    Garau J; Xercavins M; Rodríguez-Carballeira M; Gómez-Vera JR; Coll I; Vidal D; Llovet T; Ruíz-Bremón A
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2736-41. PubMed ID: 10543756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A; De Boever CM; Fabbro-Peray P; Gouby A; Sirot D; Jourdan J
    J Clin Microbiol; 2001 Feb; 39(2):438-44. PubMed ID: 11158087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections.
    Yasufuku T; Shigemura K; Shirakawa T; Nakano Y; Tanaka K; Arakawa S; Kinoshita S; Nishimura K; Kawabata M; Fujisawa M
    Scand J Infect Dis; 2011 Feb; 43(2):83-8. PubMed ID: 20942776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
    Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
    J Antimicrob Chemother; 2009 Mar; 63(3):568-74. PubMed ID: 19126669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
    Talon D; Lallemand-De-Conto S; Thouverez M; Bertrand X
    Pathol Biol (Paris); 2004 Mar; 52(2):76-81. PubMed ID: 15001235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections.
    Lautenbach E; Fishman NO; Bilker WB; Castiglioni A; Metlay JP; Edelstein PH; Strom BL
    Arch Intern Med; 2002 Nov; 162(21):2469-77. PubMed ID: 12437407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.
    Huang Y; Zhuang S; Du M
    Infection; 2007 Oct; 35(5):339-45. PubMed ID: 17721736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
    Martelius T; Jalava J; Kärki T; Möttönen T; Ollgren J; Lyytikäinen O;
    Infect Dis (Lond); 2016; 48(3):229-34. PubMed ID: 26577519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.